Analysts: Recovery Will Benefit GM and 3 More Research Notes to Check Out

General Motors (NYSE:GM): Based on expectations that shareholders will benefit from a steady recovery in the North America vehicle cycle, disciplined capital allocation, record earnings, and increasing cash returns, Sterne Agee has raised its price target on the shares, from $40 to $46, and keeps a Buy rating on the stock.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

gm

AIG (NYSE:AIG): AIG has the option to cancel its sale of 80 percent of ILFC to a Chinese consortium after a deposit deadline was missed, although Wells Fargo doesn’t expect the firm to cancel the deal. The firm keeps a Market Perform rating on the company, and notes that the closing of the deal may be later or may not happen, which could impact AIG’s capital return plans.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

aig

Guess Inc. (NYSE:GES): Solid Q1 results have led Brean Capital to raise its price target on Guess from $28 to $37, as it sees Guess’s guidance as conservative, easy comps, higher margins, and the potential for higher top and bottom line upside. Shares are rated at Buy.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

ges

Myriad Genetics (NASDAQ:MYGN):  Jefferies has brought shares of Myriad down from Buy to Hold, after assuming coverage of the stock and citing valuation concerns. Price target is $31.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

mygn

Don’t Miss: From Microsoft to Marijuana: May the Best Brand Win.